Ginkgo snaps up gene therapy vector assets from StrideBio
06 Apr 2023 //
ENDPTS
StrideBio Announces Mark Velleca, M.D., Ph.D., as Chief Executive Officer
04 Feb 2022 //
BUSINESSWIRE
StrideBio Expands Leadership Team with Accomplished Industry Executives
15 Jun 2021 //
BUSINESSWIRE
StrideBio Announces Closing of $81.5M Series B Financing
16 Mar 2021 //
PRNEWSWIRE
Strides Pharma`s Generic PREDNISONE Receives Approval In The US
13 Sep 2020 //
FDA
Sarepta brings in more gene therapies with StrideBio deal
15 Nov 2019 //
BOSPECTRUMASIA